SCPH — Scpharmaceuticals Share News
0.000.00%
Last trade - 00:00- $304.36m
- $314.75m
- $36.33m
U.S. STOCKS ON THE MOVE-Boeing, AST SpaceMobile, Syndax
scPharmaceuticals rises after beating Q2 revenue estimates
scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: scPharmaceuticals Q2 Revenue USD 8.054 Million Vs. IBES Estimate USD 7.97 Million
scPharmaceuticals Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: ScPharmaceuticals Announces FDA Approval Of Supplemental New Drug Application Expanding The Furoscix Indication In Heart Failure
Brief: ScPharmaceuticals Announces Proposed Underwritten Public Offering Of Common Stock And Pre-Funded Warrants
scPharmaceuticals Inc expected to post a loss of 40 cents a share - Earnings Preview
scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: scPharmaceuticals Q1 Revenue USD 6.102 Million Vs. IBES Estimate USD 5.98 Million
scPharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
scPharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Scpharmaceuticals May Offer &Sell Shares Of Our Common Stock Having Price Of Up To $50 Million From Time To Time Through Or To Td Cowen
U.S. RESEARCH ROUNDUP-Evercommerce, Immuneering, Ulta Beauty
scPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Scpharmaceuticals Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: scPharmaceuticals Q4 Revenue USD 6.096 Million Vs. IBES Estimate USD 5.53 Million
scPharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: scPharmaceuticals Q3 Revenue USD 3.796 Million Vs. IBES Estimate USD 3.39 Million